September 17, 2019
The Ministry of Health, Labor and Welfare (MHLW) on September 12 granted orphan drug designation to three drugs including Chugai Pharmaceutical’s satralizumab. Satralizumab was designated for an expected indication of neuromyelitis optica and associated diseases. The two other drugs are...read more